Shares Magazine
1,400.00p+0.00 (+0.00%)20 Sep 2024, 11:20
Jump to:
4Basebio PLC Fundamentals
| Company Name | 4Basebio PLC | Last Updated | 2024-09-20 |
|---|---|---|---|
| Industry | Biotechnology | Sector | Healthcare |
| Shares in Issue | 12.811 m | Market Cap | £179.35 m |
| PE Ratio | 0.00 | Dividend per Share | 0 |
| Dividend Yield | 0 | Dividend Cover | 0 |
| EPS | -£0.62 | EPS Growth (%) | 0 |
| PEG | 0 | DPS Growth (%) | 0 |
| Debt Ratio | 0.8771 | Debt Equity Ratio | 0 |
| Asset Equity Ratio | -24.2317 | Cash Equity Ratio | -6.2378 |
| Quick Ratio | 1.3948 | Current Ratio | 2.21 |
| Price To Book Value | 0 | ROCE | 0 |
4Basebio PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
4Basebio PLC Company Financials
| Assets | 2023 | 2022 | 2021 |
|---|---|---|---|
| Tangible Assets | £4.20 m | £3.63 m | £2.76 m |
| Intangible Assets | £2.67 m | £2.12 m | £1.27 m |
| Investments | 0 | 0 | 0 |
| Total Fixed Assets | £6.90 m | £5.79 m | £4.06 m |
| Stocks | £332,000.00 | £133,000.00 | £156,000.00 |
| Debtors | £107,000.00 | £54,000.00 | £46,000.00 |
| Cash & Equivalents | £3.07 m | £4.35 m | £9.59 m |
| Other Assets | 0 | 0 | 0 |
| Total Assets | £11.92 m | £11.69 m | £14.70 m |
| Liabilities | 2023 | 2022 | 2021 |
|---|---|---|---|
| Creditors within 1 year | £2.28 m | £1.52 m | £1.52 m |
| Creditors after 1 year | £10.14 m | £3.05 m | £1.48 m |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | £12.41 m | £4.57 m | £3.01 m |
| Net assets | -£492,000.00 | £7.12 m | £11.70 m |
| Equity | 2023 | 2022 | 2021 |
|---|---|---|---|
| Called up share capital | £11.13 m | £11.13 m | £11.13 m |
| Share Premium | £706,000.00 | £706,000.00 | £706,000.00 |
| Profit / Loss | -£8.35 m | -£5.93 m | -£3.64 m |
| Other Equity | -£492,000.00 | £7.12 m | £11.70 m |
| Preference & Minorities | 0 | 0 | 0 |
| Total Capital Employed | -£492,000.00 | £7.12 m | £11.70 m |
| Ratios | 2023 | 2022 | 2021 |
|---|---|---|---|
| Debt Ratio | 0 | £0.29 | £0.10 |
| Debt-to-Equity | 0 | £0.41 | £0.11 |
| Assets / Equity | -24.2317 | -24.2317 | -24.2317 |
| Cash / Equity | -6.2378 | -6.2378 | -6.2378 |
| EPS | -£0.62 | -£0.42 | -£0.24 |
| Cash Flow | 2023 | 2022 | 2021 |
|---|---|---|---|
| Cash from operating activities | -£6.18 m | -£4.70 m | -£2.74 m |
| Cashflow before financing | £247,000.00 | -£3.46 m | -£3.21 m |
| Increase in Cash | -£1.24 m | -£5.40 m | -£4.72 m |
| Income | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | £506,000.00 | £268,000.00 | £338,000.00 |
| Cost of sales | £166,000.00 | £29,000.00 | £69,000.00 |
| Gross Profit | £340,000.00 | £239,000.00 | £269,000.00 |
| Operating Profit | -£8.05 m | -£5.84 m | -£3.53 m |
| Pre-Tax profit | -£8.35 m | -£5.93 m | -£3.64 m |
4Basebio PLC Company Background
| Sector | Healthcare |
|---|---|
| Activities | 4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use. |
| Latest Interim Date | 27 Sep 2024 |
| Latest Fiscal Year End Date | 5 Jun 2024 |
4Basebio PLC Directors
| Appointed | Name | Position |
|---|---|---|
| 2021-02-12 | Mr. Timothy Paul McCarthy | Non-Executive Director,Chairman |
| 2024-09-21 | Dr. Joseph M. Fernandez | Non-Executive Director |
| 2024-06-28 | Mr. Hansjorg Plaggemars | Non-Executive Director |
| 2024-09-21 | Dr. Heikki Lanckriet, PhD | Executive Director,Chief Executive Officer |
| 2024-09-21 | Mr. David John Roth | Executive Director,Chief Financial Officer and Company Secretary |
| 2024-09-21 | Dr. Amy Jo Walker | Executive Director,Chief Operating Officer |
4Basebio PLC Contact Details
| Company Name | 4basebio PLC |
|---|---|
| Address | 25 Norman Way, Over, Cambridge, CB24 5QE |
| Telephone | +44 1223967943 |
| Website | https://www.4basebio.com |
4Basebio PLC Advisors
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Volution Group PLC | 608.00 | 9.75 |
| Essentra PLC | 148.80 | 2.62 |
| Hammerson PLC | 31.24 | 1.63 |
| Ip Group PLC | 48.50 | 1.57 |
| Apax Global Alpha Limited | 147.20 | 1.52 |
| Centamin PLC | 153.60 | 1.39 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Dr. Martens PLC | 51.65 | -19.42 |
| Close Brothers Group PLC | 431.00 | -13.45 |
| Bridgepoint Group PLC | 339.60 | -11.38 |
| Johnson Matthey PLC | 1,470.00 | -8.53 |
| Dowlais Group PLC | 58.55 | -7.21 |
| Coats Group PLC | 98.60 | -5.37 |
Risers/fallers data from previous trading day.